FDA Gives Nod to New Genetic Test for Breast Cancer Patients
The FDA has approved a genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
Read MoreMonth: July 2008
Molecular Diagnostics
AdvanDx Inc, G-Biosciences/Genotech, Gen-Probe, Luminex Corp, Nanogen Inc, Qiagen Inc, Veredus Laboratories Pte Ltd, ViraCor Laboratories, ZeptoMetrix Corp
Read MoreCdiff Assay Awaits FDA Clearance
BD Diagnostics, Franklin Lakes, NJ, reports the CE marking of the GeneOhm Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection—and the company is seeking FDA clearance for the test.
Read MoreSIRS-Lab Formulates Biomarker-Based Sepsis Test
SIRS-Lab GmbH, Jena, Germany has introduced Siqnature, a new molecular test for the early prediction and monitoring of sepsis.
Read More
Personalized Medicine Roundtable
Five companies discuss the potential and challenges of the dawning age of personalized medicine.
Read More